NO20084625L - Renininhibitorer for behandlingen av hypertensjon - Google Patents

Renininhibitorer for behandlingen av hypertensjon

Info

Publication number
NO20084625L
NO20084625L NO20084625A NO20084625A NO20084625L NO 20084625 L NO20084625 L NO 20084625L NO 20084625 A NO20084625 A NO 20084625A NO 20084625 A NO20084625 A NO 20084625A NO 20084625 L NO20084625 L NO 20084625L
Authority
NO
Norway
Prior art keywords
hypertension
treatment
renin inhibitors
methods
preventing
Prior art date
Application number
NO20084625A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Satlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084625(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20084625L publication Critical patent/NO20084625L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20084625A 2006-04-03 2008-11-03 Renininhibitorer for behandlingen av hypertensjon NO20084625L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
PCT/US2007/065564 WO2007118023A1 (fr) 2006-04-03 2007-03-30 Inhibiteurs de la rénine destinés au traitement de l'hypertension

Publications (1)

Publication Number Publication Date
NO20084625L true NO20084625L (no) 2008-11-03

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084625A NO20084625L (no) 2006-04-03 2008-11-03 Renininhibitorer for behandlingen av hypertensjon

Country Status (20)

Country Link
US (1) US20090062395A1 (fr)
EP (1) EP2004167A1 (fr)
JP (1) JP2009532494A (fr)
KR (1) KR20080108515A (fr)
CN (1) CN101415413A (fr)
AU (1) AU2007234917B2 (fr)
BR (1) BRPI0710095A2 (fr)
CA (1) CA2645260A1 (fr)
CL (1) CL2007000912A1 (fr)
IL (1) IL193905A0 (fr)
MA (1) MA30387B1 (fr)
MX (1) MX2008012729A (fr)
NO (1) NO20084625L (fr)
NZ (1) NZ571251A (fr)
RU (1) RU2008143055A (fr)
SG (1) SG170830A1 (fr)
TN (1) TNSN08383A1 (fr)
TW (1) TW200806283A (fr)
WO (1) WO2007118023A1 (fr)
ZA (1) ZA200807615B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (fr) * 2008-01-11 2009-07-16 Novartis Ag Utilisation de composés organiques
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
US20140248284A1 (en) 2011-10-20 2014-09-04 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for the detection and the treatment of cardiac remodeling
WO2020214851A1 (fr) * 2019-04-18 2020-10-22 Aerpio Pharmaceuticals, Inc. Méthode de traitement de l'hypertension avec des activateurs de tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
WO2004002549A1 (fr) * 2002-06-28 2004-01-08 Novartis Ag Utilisation de composes organiques
WO2004100871A2 (fr) * 2003-05-09 2004-11-25 Pharmacia Corporation Combinaison d'un antagoniste du recepteur de l'aldosterone et d'un inhibiteur de renine
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
AR048431A1 (es) * 2004-03-17 2006-04-26 Novartis Ag Formulaciones galenicas de compuestos organicos
WO2006036054A1 (fr) * 2004-09-27 2006-04-06 Pantarhei Bioscience B.V. Traitement preventif contre les saignements imprevus chez les femmes sous traitement contenant un progestogene

Also Published As

Publication number Publication date
JP2009532494A (ja) 2009-09-10
AU2007234917B2 (en) 2011-05-12
TW200806283A (en) 2008-02-01
CA2645260A1 (fr) 2007-10-18
RU2008143055A (ru) 2010-05-10
CL2007000912A1 (es) 2008-03-14
SG170830A1 (en) 2011-05-30
BRPI0710095A2 (pt) 2011-08-02
ZA200807615B (en) 2009-10-28
MX2008012729A (es) 2008-10-14
TNSN08383A1 (en) 2009-12-29
WO2007118023A1 (fr) 2007-10-18
NZ571251A (en) 2011-12-22
EP2004167A1 (fr) 2008-12-24
KR20080108515A (ko) 2008-12-15
US20090062395A1 (en) 2009-03-05
MA30387B1 (fr) 2009-05-04
CN101415413A (zh) 2009-04-22
IL193905A0 (en) 2009-08-03
AU2007234917A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
EA200970856A1 (ru) Ингибиторы пути хеджхога
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
UA95955C2 (ru) Ингибиторы обратной транскриптазы вич
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
WO2008049000A3 (fr) Thérapie de combinaison pour l&#39;hypertension artérielle pulmonaire
WO2007101232A3 (fr) Inhibition de jak2 pour traiter l&#39;hypertension artérielle pulmonaire
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA201070786A1 (ru) Бензофуропиримидиноны
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
NO20070917L (no) Imidazotriaziner som protein-kinaseinhibitorer
UA94129C2 (ru) Соединения для ингибирования митоза
MX2009004984A (es) Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
GEP20125708B (en) Hydroxamate-based inhibitors of deacetylases b
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
IN2012DN01273A (fr)
WO2008030795A3 (fr) Compositions et procédés d&#39;inhibition de tyrosine kinases
WO2007140317A3 (fr) Méthodes d&#39;utilisation d&#39;inhibiteurs de la phospholipase a2 cytosolique dans le traitement de la thrombose
EA200970164A1 (ru) Ингибиторы каспазы на основе пиридазинонового каркаса
EP1599201A4 (fr) Modulateurs selectifs de recepteurs de glucocorticoides non steroidaux
TNSN08383A1 (en) Renin inhibitors for the treatment of hypertension
EP2248520A3 (fr) Utilisation d&#39;inhibiteurs de rénine pour la prévention ou le traitement du dysfonctionnement diastolique ou de la cardiopathie diastolique
WO2009148600A8 (fr) Composés à base de lysine deutérée
DK1791537T3 (da) 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase
WO2007044325A3 (fr) Inhibiteurs de l&#39;interaction du domaine apoe4 et methodes d&#39;utilisation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application